Stifel analyst Mark Astrachan upgraded Colgate-Palmolive (NYSE: CL) shares to Buy from Hold, reducing the price target to $81 from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE